These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 10484397

  • 1. Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice.
    de la Coste A, Fabre M, McDonell N, Porteu A, Gilgenkrantz H, Perret C, Kahn A, Mignon A.
    Am J Physiol; 1999 Sep; 277(3):G702-8. PubMed ID: 10484397
    [Abstract] [Full Text] [Related]

  • 2. Akt protects mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis through NK-kappa B activation.
    Hatano E, Brenner DA.
    Am J Physiol Gastrointest Liver Physiol; 2001 Dec; 281(6):G1357-68. PubMed ID: 11705740
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor alpha protects against Fas-mediated liver apoptosis in mice.
    Kanda D, Takagi H, Toyoda M, Horiguchi N, Nakajima H, Otsuka T, Mori M.
    FEBS Lett; 2002 May 22; 519(1-3):11-5. PubMed ID: 12023010
    [Abstract] [Full Text] [Related]

  • 4. A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection.
    Rodriguez I, Matsuura K, Khatib K, Reed JC, Nagata S, Vassalli P.
    J Exp Med; 1996 Mar 01; 183(3):1031-6. PubMed ID: 8642244
    [Abstract] [Full Text] [Related]

  • 5. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
    Nakama T, Hirono S, Moriuchi A, Hasuike S, Nagata K, Hori T, Ido A, Hayashi K, Tsubouchi H.
    Hepatology; 2001 Jun 01; 33(6):1441-50. PubMed ID: 11391533
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL.
    Kovalovich K, Li W, DeAngelis R, Greenbaum LE, Ciliberto G, Taub R.
    J Biol Chem; 2001 Jul 13; 276(28):26605-13. PubMed ID: 11349125
    [Abstract] [Full Text] [Related]

  • 7. The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver.
    Terradillos O, de La Coste A, Pollicino T, Neuveut C, Sitterlin D, Lecoeur H, Gougeon ML, Kahn A, Buendia MA.
    Oncogene; 2002 Jan 17; 21(3):377-86. PubMed ID: 11821950
    [Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis: role of nuclear factor-kappaB.
    Nagaki M, Naiki T, Brenner DA, Osawa Y, Imose M, Hayashi H, Banno Y, Nakashima S, Moriwaki H.
    Hepatology; 2000 Dec 17; 32(6):1272-9. PubMed ID: 11093734
    [Abstract] [Full Text] [Related]

  • 9. Tumor necrosis factor signaling in hepatocyte apoptosis.
    Hatano E.
    J Gastroenterol Hepatol; 2007 Jun 17; 22 Suppl 1():S43-4. PubMed ID: 17567463
    [Abstract] [Full Text] [Related]

  • 10. Hepatocyte growth factor protects against Fas-mediated liver apoptosis in transgenic mice.
    Suzuki H, Toyoda M, Horiguchi N, Kakizaki S, Ohyama T, Takizawa D, Ichikawa T, Sato K, Takagi H, Mori M.
    Liver Int; 2009 Nov 17; 29(10):1562-8. PubMed ID: 19725891
    [Abstract] [Full Text] [Related]

  • 11. Bcl-xL functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells.
    Srinivasan A, Li F, Wong A, Kodandapani L, Smidt R, Krebs JF, Fritz LC, Wu JC, Tomaselli KJ.
    J Biol Chem; 1998 Feb 20; 273(8):4523-9. PubMed ID: 9468507
    [Abstract] [Full Text] [Related]

  • 12. Novel role for amphiregulin in protection from liver injury.
    Berasain C, García-Trevijano ER, Castillo J, Erroba E, Santamaría M, Lee DC, Prieto J, Avila MA.
    J Biol Chem; 2005 May 13; 280(19):19012-20. PubMed ID: 15753092
    [Abstract] [Full Text] [Related]

  • 13. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) promotes mitochondrial dysfunction and apoptosis induced by 7-hydroxystaurosporine and mitogen-activated protein kinase kinase inhibitors in human leukemia cells that ectopically express Bcl-2 and Bcl-xL.
    Dai Y, Dent P, Grant S.
    Mol Pharmacol; 2003 Dec 13; 64(6):1402-9. PubMed ID: 14645670
    [Abstract] [Full Text] [Related]

  • 14. Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation.
    Yang S, Lin H, Diehl AM.
    Am J Physiol Gastrointest Liver Physiol; 2001 Aug 13; 281(2):G382-92. PubMed ID: 11447019
    [Abstract] [Full Text] [Related]

  • 15. Antisense oligonucleotide inhibition of Bcl-xL and Bid expression in liver regulates responses in a mouse model of Fas-induced fulminant hepatitis.
    Zhang H, Taylor J, Luther D, Johnston J, Murray S, Wyatt JR, Watt AT, Koo S, York-DeFalco C, Stecker K, Dean NM.
    J Pharmacol Exp Ther; 2003 Oct 13; 307(1):24-33. PubMed ID: 12893848
    [Abstract] [Full Text] [Related]

  • 16. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
    Hatano E, Bennett BL, Manning AM, Qian T, Lemasters JJ, Brenner DA.
    Gastroenterology; 2001 Apr 13; 120(5):1251-62. PubMed ID: 11266388
    [Abstract] [Full Text] [Related]

  • 17. The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type.
    Foghsgaard L, Jäättelä M.
    J Virol; 1997 Oct 13; 71(10):7509-17. PubMed ID: 9311830
    [Abstract] [Full Text] [Related]

  • 18. The bcl, NFkappaB and p53/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-beta or TNF-alpha on activated hepatic stellate cells.
    Saile B, Matthes N, El Armouche H, Neubauer K, Ramadori G.
    Eur J Cell Biol; 2001 Aug 13; 80(8):554-61. PubMed ID: 11561906
    [Abstract] [Full Text] [Related]

  • 19. Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis.
    Fornoni A, Li H, Foschi A, Striker GE, Striker LJ.
    Am J Pathol; 2001 Jan 13; 158(1):275-80. PubMed ID: 11141501
    [Abstract] [Full Text] [Related]

  • 20. Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure.
    Kim SJ, Cho HI, Kim SJ, Park JH, Kim JS, Kim YH, Lee SK, Kwak JH, Lee SM.
    Eur J Pharmacol; 2014 Sep 05; 738():66-73. PubMed ID: 24877692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.